Mengdi Zhu
- Cancer Research top 10%
-
- Natural product bioactivities and synthesis 8
- Toxicology top 10%
- Bioactive Compounds and Antitumor Agents 2
-
- Microbial Natural Products and Biosynthesis 3
-
- Phytochemistry and Biological Activities 4
-
- Advanced Breast Cancer Therapies 3
-
- Tissue Engineering and Regenerative Medicine 2
-
- Reproductive Biology and Fertility 2
-
- Allergic Rhinitis and Sensitization 2
- Partner nations
- ChinaUnited StatesEgypt
In The Last Decade
Mengdi Zhu
46 papers receiving 834 citations
Peers
Comparison fields: 5 of 98
- Complementary and alternative medicine 116
- Cancer Research 161
- Molecular Biology 469
- Toxicology 21
- Pharmacology 87
Countries citing papers authored by Mengdi Zhu
This map shows the geographic impact of Mengdi Zhu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mengdi Zhu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mengdi Zhu more than expected).
Fields of papers citing papers by Mengdi Zhu
This network shows the impact of papers produced by Mengdi Zhu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mengdi Zhu. The network helps show where Mengdi Zhu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mengdi Zhu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 1 | |
| 4 | 2025 | 0 | |
| 5 | 2024 | 8 | |
| 6 | 2024 | 5 | |
| 7 | 2023 | 9 | |
| 8 | 2023 | 8 | |
| 9 | 2023 | 6 | |
| 10 | 2023 | 4 | |
| 11 | 2023 | 16 | |
| 12 | 2023 | 6 | |
| 13 | 2023 | 4 | |
| 14 | 2022 | 7 | |
| 15 | 2022 | 6 | |
| 16 | 2022 | 16 | |
| 17 | 2021 | 12 | |
| 18 | 2021 | 10 | |
| 19 | 2020 | 149 | |
| 20 | 2015 | 7 |
About Mengdi Zhu
Mengdi Zhu is a scholar working on Toxicology, Complementary and alternative medicine and Otorhinolaryngology, having authored 51 papers that have together received 842 indexed citations. Recurring topics across this work include Natural product bioactivities and synthesis (8 papers), Phytochemistry and Biological Activities (4 papers), Microbial Natural Products and Biosynthesis (3 papers), Advanced Breast Cancer Therapies (3 papers), Bioactive Compounds and Antitumor Agents (2 papers), Tissue Engineering and Regenerative Medicine (2 papers), Reproductive Biology and Fertility (2 papers) and Allergic Rhinitis and Sensitization (2 papers). The work is most often cited by research in Complementary and alternative medicine (116 citations), Cancer Research (161 citations) and Molecular Biology (469 citations). Mengdi Zhu has collaborated with scholars based in China, United States and Egypt. Frequent co-authors include Huawei Lv, Jian‐Guang Luo, Ling‐Yi Kong, Yujie Liu, Qiang Liu, Shunying Li, Hongna Lai, Liang Jin, Zijie Cai and Shengqiang Tong.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.